![Cells | Free Full-Text | Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response Cells | Free Full-Text | Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response](https://www.mdpi.com/cells/cells-11-01959/article_deploy/html/images/cells-11-01959-g003.png)
Cells | Free Full-Text | Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response
![Cells | Free Full-Text | Role of NF-κB in Ageing and Age-Related Diseases: Lessons from Genetically Modified Mouse Models Cells | Free Full-Text | Role of NF-κB in Ageing and Age-Related Diseases: Lessons from Genetically Modified Mouse Models](https://pub.mdpi-res.com/cells/cells-10-01906/article_deploy/html/images/cells-10-01906-g001-550.jpg?1627474382)
Cells | Free Full-Text | Role of NF-κB in Ageing and Age-Related Diseases: Lessons from Genetically Modified Mouse Models
![Cells | Free Full-Text | Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response Cells | Free Full-Text | Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response](https://www.mdpi.com/cells/cells-11-01959/article_deploy/html/images/cells-11-01959-g002.png)